Opportunity
INTENT TO SOLE SOURCE Geno/Grinders 2010 Tissue Homegenizer (Brand Name)
Response due
August 31, 2026
- Agency
- FDA Office of Acq Grant Svcs
- Estimated value
- Not stated
The FDA / Office of Laboratory Operations & Applied Science (OLOAS) / Office of Regulatory Testing & Surveillance (ORTS) and Office of Chemistry & Toxicology (OCT) requires seven (7) units of the Cole-Parmer Geno/Grinder® 2010 High-Throughput Homogenizer (referred to herein as "Geno/Grinder® 2010") for distribution to seven (7) FDA/OLOAS laboratories for use in regulatory sample preparation. This will be a Firm Fixed Price contract with a one-year period of performance.
Key dates
- Posted
- August 21, 2026
- Response due
- August 31, 2026
Who is this buyer
Organization
Buying history
- Records104 total
- Opportunities / awards0 / 16
- Value range$305 – $10,856,214
- ActiveJuly 17, 2026 – October 17, 2026
What they buy
- Clinical (96)
- Administrative (8)
Set-asides used
- No Set aside used (57)
- Small Business Set Aside - Total (13)
- 8(a) Set-Aside (FAR 19.8) (1)
- 8(a) Sole Source (FAR 19.8) (1)
Who holds their work today
- EAGLE HEALTH, LLC2 wins · $15,051,897 · last February 27, 2023
- SERVEFED INC.1 win · $10,844,558 · last July 12, 2024
- UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES3 wins · $285,145 · last July 18, 2025
- KATMAI COMMODITIES, LLC1 win · $104,123 · last May 16, 2023
- STEMEXPRESS, LLC2 wins · $98,658 · last September 6, 2024
View source document →
Source link on sam.gov.
Source record
- Buyer type
- Federal
- Jurisdiction
- Federal (US)
- Category
- Clinical
- Set-aside
- Not stated
- NAICS
- 334516
- PSC
- 6640